ERBB2 and triple-negative breast carcinoma: Tumors expressing human epidermal growth factor receptor 2 (HER2) are HER2 enriched (whether or not luminal), and tumors that lack the expression of hormone receptors and HER2 enrichment are triple-negative breast cancer (TNBC).(3)